RewiredBio
RewiredBio uses AI to analyze protein data and design drugs that reduce off-target effects. The company combines proprietary synthetic biology techniques with machine learning and protein-folding models to engineer and predict protein behavior for therapeutic use. It operates as a biotechnology drug-discovery and protein-analysis platform leveraging artificial intelligence and computational protein design. RewiredBio's approach targets a pathway implicated in over 90% of cancers and focuses on producing smarter, more specific therapeutics. The platform is positioned for collaboration with pharmaceutical companies and research institutions for drug discovery and protein analysis.
RewiredBio
RewiredBio uses AI to analyze protein data and design drugs that reduce off-target effects. The company combines proprietary synthetic biology techniques with machine learning and protein-folding models to engineer and predict protein behavior for therapeutic use. It operates as a biotechnology drug-discovery and protein-analysis platform leveraging artificial intelligence and computational protein design. RewiredBio's approach targets a pathway implicated in over 90% of cancers and focuses on producing smarter, more specific therapeutics. The platform is positioned for collaboration with pharmaceutical companies and research institutions for drug discovery and protein analysis.